Farxiga Could See Robust Demand in International Markets in 2017 http://marketrealist.com/?p=2188432 $AZN $JNJ $LLY $MRK $PPH
7/11 200D MA Watch List: $XME $MRK $IYR $BUD $ETE $WY $AIG $AMGN $POT $NUE $ALXN $LULU $ULTA $EPD $HST $PG $UPS $PAY $FOXA $TLT
How Celgene Stock Performed in 2Q17 http://marketrealist.com/?p=2190727 $AMGN $CELG $IXJ $MRK $PFE
Farxiga Expected to Drive AstraZeneca’s Performance in Diabetes Segment http://marketrealist.com/?p=2188389 $AZN $JNJ $LLY $MRK $VEU
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
Bloggers are bullish on $MRK: https://www.finstead.com/symbol/info/MRK/bloggers
Cybersecurity Stocks Gain as Mondelez Loses Sales to Petya  http://buff.ly/2tHJ0TE  $FTNT $MANT $SYMC $FDX $MRK $MDLZ $CUDA $PANW $FEYE
Buy Side Closing Order Imbalances $T $GM $IBM $MRK $RAI $DVN $MET $CVX $EGN $EXC $LB $UNP $WEC $XYL $XOM $JNPR $OKE https://marketchameleon.com/Reports/StockOrderImbalanceReport
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now http://bit.ly/100717CELG $CELG $PFE $MRK $BMY
$VSTM $MRK Is working w/VSTM on a blockbuster FAK inhibitor, thats the real reason why getting it this cheap is a steal. This is a 5yr hold.
$MRK buying at the 200m a has worked well since Dec. Here we are again
$mrk starter long via calls on megaphone tl tag
$MRK Bought some weakness here
$BLRX will be next $AVEO after Phase 2-cancer trial results with a combo of the company&#39;s BL-8040 &amp; $MRK KEYTRUDA are out by the end of July
Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://wp.me/p5bLGB-5HlX
Inside BMY&#39;s Yervoy: What the Revenue Trends Tell Us http://marketrealist.com/?p=2187026 $BMY $MRK $NVS $RHHBY $VYM
$MRK #LargePharmaceuticals sector comp is now available http://link.scoutfin.com/8gyk/JbacAGUimD
PDS Biotechnology, $MRK to Evaluate Combo of Versamune/KEYTRUDA for Metastatic Head and Neck Cancer http://crweworld.com/newsroom/prnewswire?rkey=20170710CL34563&amp;filter=10284
$BLRX Heavy newsflow for 2H 2017 &amp; 1H 2018 started today. The big one later this month Phase 2 with $MRK KEYTRUDA
A Look at Merck and Co.&#39;s Performance in 2Q17 http://marketrealist.com/?p=2190035 $ABBV $AGN $BMY $MRK $VHT
7/10 200D MA Watch List: $NUE $CARA $ETE $PAY $ALXN $S $CBS $INFY $ZIOP $AMGN $MRK $MT $PG $PANW $SHAK $JWN $LULU $COF $EPD $WY
Tagrisso Expected to Be a Key Growth Driver for AstraZeneca in 2017 http://staging.marketrealist.com/?p=2187735 $AZN $VXUS $RHHBY $MRK $BMY
Tagrisso Expected to Be a Key Growth Driver for AstraZeneca in 2017 http://marketrealist.com/?p=2187735 $AZN $BMY $MRK $RHHBY $VXUS
How 2Q17 Is Shaping Up for Pfizer http://marketrealist.com/?p=2189972 $BIIB $FHLC $GILD $MRK $PFE
How 2Q17 Is Shaping Up for Pfizer http://staging.marketrealist.com/?p=2189972 $PFE $BIIB $MRK $GILD $FHLC
$MRK estimates distribution - here’s what 12 Estimize analysts are expecting $MRK to report for Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
Market Strategies for July 10 - 14 $AAPL, $VOXX, $HL, $OZRK, $NUGT, $CBSH, $SJM, $FRC, $MRK, $VIX, $LRCX, $SIMO, $PN http://crweworld.com/article/markets/114963/jul-10-14-2017-weekly-market-strategies
$MRK  saw some JULY bull flow to end the week.  Sentiment washed out pretty nice here, let&#39;s see if they come back for more early in week.
10 Stocks = 64% Of Market&#39;s Top Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2uAXiWf
Joy Division Unknown Pleasures but with a chart of $MRK - who&#39;s done it or will soon?
